Aurobindo Pharma (NSE:AUROPHARMA) Receivables Turnover : 1.56 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Aurobindo Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Aurobindo Pharma's Revenue for the three months ended in Mar. 2024 was ₹74,919 Mil. Aurobindo Pharma's average Accounts Receivable for the three months ended in Mar. 2024 was ₹48,167 Mil. Hence, Aurobindo Pharma's Receivables Turnover for the three months ended in Mar. 2024 was 1.56.

Aurobindo Pharma Receivables Turnover Historical Data

The historical data trend for Aurobindo Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Receivables Turnover Chart

Aurobindo Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

Get a 7-Day Free Trial

5.88

6.28

6.22

5.81

6.18

Aurobindo Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															1.43	1.52	1.54	1.57	1.56

Competitive Comparison of Aurobindo Pharma's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurobindo Pharma's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Aurobindo Pharma's Receivables Turnover falls into.

Aurobindo Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Aurobindo Pharma's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	287045	/ (	(44663.8	+	48167.4)	/	2 )
=	287045	/	46415.6
=	6.18

Aurobindo Pharma's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	74919.2	/ (	(0	+	48167.4)	/	1 )
=	74919.2	/	48167.4
=	1.56

Aurobindo Pharma (NSE:AUROPHARMA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Aurobindo Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma (NSE:AUROPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (NSE:AUROPHARMA) » Definitions » Receivables Turnover

Traded in Other Exchanges

524804:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (NSE:AUROPHARMA) Headlines

No Headlines